This Herrenhausen Conference focuses on major scientific and ethical challenges of novel neurological interventions and how they can be overcome. Participants will explore how critically needed trials of new treatment modalities can be launched safely and conducted ethically.
Since most major neurological disorders like Alzheimer's, traumatic brain injuries, Amyothrophic Lateral Sclerosis, and many others have no cure, the despair of patients means they often fail to consider the major risks intrinsic to early clinical trials of novel modalities such as stem cell interventions and gene therapy.
While these new pathways to potential treatments need to be pursued, they are being developed in a climate that often is not conducive to good science. Factors such as concerns about irreproducible research results, researchers' needs to divide their time between their research and pursuing funding, and the inflated expectations produced by science hype can all hinder efforts to conduct investigations carefully and responsibly.
To help improve this problematic climate, the Herrenhausen Conference will address:
1. The personal despair and public hype that frame contemporary scientific research in neurological disease. 2. Deficiencies in pre-clinical neurological research and how to overcome them in order to increase the safety and predictive value of early trials of novel neurological interventions.
3. Strategies that can improve the informed consent processes for trials of these novel interventions.
The conference will seek clear deliverables to improve the robustness and positive predictive value of pre-clinical research, protect the welfare of research participants, and develop more effective informed consent processes.
We invite all researchers and experts working in this field.
There is no fee for the attendance, but registration is essential.
Travel Grants available!
Registration & Programme: https://www.volkswagenstiftung.de/nc/veranstaltungen/veranstaltungskalender/veranstdet/news/detail/artikel/lost-in-the-maze-navigating-evidence-and-ethics-in-translational-neuroscience/marginal/5277.html